155 related articles for article (PubMed ID: 33744337)
1. Evaluation of influenza A and B cold-adapted reassortant virus reproduction in trivalent live influenza vaccines.
Landgraf G; Desheva YA; Rudenko LG
Virus Res; 2021 Jul; 300():198396. PubMed ID: 33744337
[TBL] [Abstract][Full Text] [Related]
2. Assessment of trivalent live influenza vaccines in MDCK cell line.
Landgraf G; Desheva YA; Rudenko LG
MethodsX; 2021; 8():101442. PubMed ID: 34430331
[TBL] [Abstract][Full Text] [Related]
3. Rationale for vaccination with trivalent or quadrivalent live attenuated influenza vaccines: Protective vaccine efficacy in the ferret model.
Rudenko L; Kiseleva I; Krutikova E; Stepanova E; Rekstin A; Donina S; Pisareva M; Grigorieva E; Kryshen K; Muzhikyan A; Makarova M; Sparrow EG; Torelli G; Kieny MP
PLoS One; 2018; 13(12):e0208028. PubMed ID: 30507951
[TBL] [Abstract][Full Text] [Related]
4. Protective efficacy in mice of monovalent and trivalent live attenuated influenza vaccines in the background of cold-adapted A/X-31 and B/Lee/40 donor strains.
Jang YH; Lee EY; Byun YH; Jung EJ; Lee YJ; Lee YH; Lee KH; Lee J; Seong BL
Vaccine; 2014 Jan; 32(5):535-43. PubMed ID: 24342248
[TBL] [Abstract][Full Text] [Related]
5. Safety and immunogenicity in man of a cell culture derived trivalent live attenuated seasonal influenza vaccine: a Phase I dose escalating study in healthy volunteers.
Heldens J; Hulskotte E; Voeten T; Breedveld B; Verweij P; van Duijnhoven W; Rudenko L; van Damme P; van den Bosch H
Vaccine; 2014 Sep; 32(39):5118-24. PubMed ID: 24858566
[TBL] [Abstract][Full Text] [Related]
6. Comparison of egg and high yielding MDCK cell-derived live attenuated influenza virus for commercial production of trivalent influenza vaccine: in vitro cell susceptibility and influenza virus replication kinetics in permissive and semi-permissive cells.
Hussain AI; Cordeiro M; Sevilla E; Liu J
Vaccine; 2010 May; 28(22):3848-55. PubMed ID: 20307595
[TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blind noninferiority study of quadrivalent live attenuated influenza vaccine in adults.
Block SL; Yi T; Sheldon E; Dubovsky F; Falloon J
Vaccine; 2011 Nov; 29(50):9391-7. PubMed ID: 21983154
[TBL] [Abstract][Full Text] [Related]
8. Alternative Strategy for a Quadrivalent Live Attenuated Influenza Virus Vaccine.
Wan Z; Cardenas Garcia S; Liu J; Santos J; Carnaccini S; Geiger G; Ferreri L; Rajao D; Perez DR
J Virol; 2018 Nov; 92(21):. PubMed ID: 30135124
[TBL] [Abstract][Full Text] [Related]
9. Generation of DelNS1 Influenza Viruses: a Strategy for Optimizing Live Attenuated Influenza Vaccines.
Wang P; Zheng M; Lau SY; Chen P; Mok BW; Liu S; Liu H; Huang X; Cremin CJ; Song W; Chen Y; Wong YC; Huang H; To KK; Chen Z; Xia N; Yuen KY; Chen H
mBio; 2019 Sep; 10(5):. PubMed ID: 31530680
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity and Viral Shedding of Russian-Backbone, Seasonal, Trivalent, Live, Attenuated Influenza Vaccine in a Phase II, Randomized, Placebo-Controlled Trial Among Preschool-Aged Children in Urban Bangladesh.
Lewis KDC; Ortiz JR; Rahman MZ; Levine MZ; Rudenko L; Wright PF; Katz JM; Dally L; Rahman M; Isakova-Sivak I; Ilyushina NA; Matyushenko V; Fry AM; Lindstrom SE; Bresee JS; Brooks WA; Neuzil KM
Clin Infect Dis; 2019 Aug; 69(5):777-785. PubMed ID: 30481272
[TBL] [Abstract][Full Text] [Related]
11. Comparison of live, attenuated H1N1 and H3N2 cold-adapted and avian-human influenza A reassortant viruses and inactivated virus vaccine in adults.
Sears SD; Clements ML; Betts RF; Maassab HF; Murphy BR; Snyder MH
J Infect Dis; 1988 Dec; 158(6):1209-19. PubMed ID: 3198936
[TBL] [Abstract][Full Text] [Related]
12. [Genome composition analysis of the reassortant influenza viruses used in seasonal and pandemic live attenuated influenza vaccine].
Kiseleva IV; Voeten JT; Teley LC; Larionova NV; Dubrovina IA; Berdygulova ZhA; Bazhenova EA; van den Bosch H; Heldens JG; Rudenko LG
Mol Gen Mikrobiol Virusol; 2011; (4):29-36. PubMed ID: 22312898
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity and efficacy of the monovalent, trivalent and quadrivalent intranasal live attenuated influenza vaccines containing different pdmH1N1 strains.
Yeolekar LR; Ganguly M; Tyagi P; Ingle NB; Stittelaar KJ; Waal L; Scorza FB; Mahmood K; Dhere RM
Vaccine; 2018 Nov; 36(46):6944-6952. PubMed ID: 30322745
[TBL] [Abstract][Full Text] [Related]
14. Immunization of institutionalized asthmatic children and patients with psychomotor retardation using live attenuated cold-adapted reassortment influenza A H1N1, H3N2 and B vaccines.
Miyazaki C; Nakayama M; Tanaka Y; Kusuhara K; Okada K; Tokugawa K; Ueda K; Shibata R; Nishima S; Yamane N
Vaccine; 1993; 11(8):853-8. PubMed ID: 8356846
[TBL] [Abstract][Full Text] [Related]
15. Genetic stability of live attenuated vaccines against potentially pandemic influenza viruses.
Kiseleva I; Dubrovina I; Fedorova E; Larionova N; Isakova-Sivak I; Bazhenova E; Pisareva M; Kuznetsova V; Flores J; Rudenko L
Vaccine; 2015 Dec; 33(49):7008-14. PubMed ID: 26432909
[TBL] [Abstract][Full Text] [Related]
16. Nasal shedding of vaccine viruses after immunization with a Russian-backbone live attenuated influenza vaccine in India.
Dar L; Krishnan A; Kumar R; Dhakad S; Choudekar A; Bagga S; Sharma A; Kumar A; Jethani J; Saha S; Amarchand R; Kumar R; Choudhary A; Narayan VV; Gopal G; Lafond KE; Lindstrom S
Influenza Other Respir Viruses; 2023 Jun; 17(6):e13149. PubMed ID: 37380175
[TBL] [Abstract][Full Text] [Related]
17. [DEVELOPMENT OF THE QUADRIVALENT LIVE ATTENUATED INFLUENZA VACCINE INCLUDING TWO INFLUENZA B LINEAGES--VICTORIA AND YAMAGATA].
Desheva YA; Smolonogina TA; Doroshenko EM; Rudenko LG
Vopr Virusol; 2016; 61(1):16-20. PubMed ID: 27145595
[TBL] [Abstract][Full Text] [Related]
18. Generation and evaluation of the trivalent inactivated reassortant vaccine using human, avian, and swine influenza A viruses.
Du N; Li W; Li Y; Liu S; Sui Y; Qu Z; Wang Y; Du Y; Xu B
Vaccine; 2008 Jun; 26(23):2912-8. PubMed ID: 18448208
[TBL] [Abstract][Full Text] [Related]
19. T-cell-mediated cross-strain protective immunity elicited by prime-boost vaccination with a live attenuated influenza vaccine.
Li J; Arévalo MT; Chen Y; Chen S; Zeng M
Int J Infect Dis; 2014 Oct; 27():37-43. PubMed ID: 25172265
[TBL] [Abstract][Full Text] [Related]
20. Safety, Immunogenicity, and Protective Efficacy of a Chimeric A/B Live Attenuated Influenza Vaccine in a Mouse Model.
Stepanova E; Krutikova E; Wong PF; Matyushenko V; Bazhenova E; Isakova-Sivak I; Rudenko L
Microorganisms; 2021 Jan; 9(2):. PubMed ID: 33513862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]